Diabetes

Type 2 Diabetes Type 1 Diabetes Medications Treatment Options Diabetes Management Prediabetes Management Complications Treatment Blood Sugar Control Risk Factors Diabetes Medications Insulin Symptoms Obesity Blood Sugar Regulation Insulin Products Insulin Management Gestational Diabetes Insulin Therapy Dietary Management Types of Diabetes Statistics Blood Sugar Management Medication Diabetic Ketoacidosis Insulin Resistance Insulin Treatment Prevention Diagnosis Weight Loss Type 5 Diabetes GLP-1 Drugs Type-2 Diabetes Diabetic Complications Prevalence Research Medical Care Type II Diabetes Blood Glucose Monitoring Hypoglycemia Awareness Campaigns Diabetic Medications GLP-1 Therapies Medical Devices GLP-1 Receptor Agonists Diabetes Types Insulin Production Healthcare Sugar Consumption Type 1 Diabetes Drugs Ozempic Use in Diabetes Patients Management Tips Medication Management Blood Glucose Control Skin Conditions Type 2 Diabetes Treatments Type 2 Diabetes Management Blood Sugar Monitoring Chronic Conditions Dietary Needs Research Innovations Diabetic Products Healthcare Access Biomarkers Consultation Cognitive Impairment Research Organizations Yoga and Health Screening Management Solutions Myths and Misconceptions Awareness and Education Glycaemic Control Global Trends Health Scares Pancreas Continuous Glucose Monitoring Global Health Global Health Issues Insulin Delivery Diabetes Treatment Diabetic Foot Type-5 Diabetes Pre-Diabetes Monitoring Devices Public Health Pre-diabetes Advertising Type 2 Diabetes Mellitus Causes Health Complications Monitoring Systems Diabetes Mellitus Type 2 GLP-1 Therapy Treatment Strategies Insulin Deficiency Alzheimer's Disease Demographics

U.S. Gestational Diabetes Climbed 36% Since 2016, New National Study Shows

Researchers tie the trend to declining young adult health.

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

Bringing Blood Sugar to Normal in Prediabetes Halves Major Heart Risks, Study Finds

MIT’s Light-Based Glucose Monitor Matches CGMs in Early Test as Wearable Trials Begin

Study Finds Early T1D CD4 T-Cell Signature in Pancreatic Lymph Nodes

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

Brain Maps of GLP-1 Drugs Point to Paths for Weight Loss Without Nausea

GLP-1 Drugs Linked to Lower Five-Year Death Risk in Colon Cancer, UCSD Study Finds

Randomized Trial Finds Metformin Dulls Key Gains From Exercise

Mouse Study Finds Resistance Training Outperforms Running for Metabolic Health

GLP-1 Drugs Plus Healthy Habits Linked to Bigger Heart Risk Drop in Veterans With Type 2 Diabetes

Dexcom Tops Q3 Estimates and Lifts 2025 Sales Outlook as Shares Slide

Jury Weighs Sentence for Sarah Hartsfield After Murder Conviction

Study Finds CGMs Track HbA1c in Type 2 Diabetes but Not in People Without Diabetes

Scientists Urge Tailored Care as IDF-Recognized Type 5 Diabetes Gains Ground

Common Genetic Variant Skews HbA1c, Delaying Diabetes Diagnosis in Black and South Asian Men

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case

Arecor and Sequel to Co-Develop AT278 With Twiist AID for High-Dose Diabetes Care

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch